You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase%20III%20study

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pyoderma Gangrenosum Trial (IFX-1, Placebo)

Not yet recruiting
  • Pyoderma Gangrenosum
  • (no location specified)
Jul 28, 2023

Essential Hypertension Trial (NW Roselle, Captopril 25Mg Tab)

Not yet recruiting
  • Essential Hypertension
  • NW Roselle
  • Captopril 25Mg Tab
  • (no location specified)
Nov 15, 2023

Cardiac Rehabilitation, Physical Activity Trial in Orlando (Mhealth)

Recruiting
  • Cardiac Rehabilitation
  • Physical Activity
  • Mhealth
  • Orlando, Florida
    AdventHealth University
Mar 21, 2023

Osteoarthritis, Knee Trial in Seoul (SKCPT, Celebrex)

Completed
  • Osteoarthritis, Knee
  • Seoul, Korea, Republic of
    Asan Medical Center
Jul 3, 2023

First Progression of Glioblastoma Trial (Lomustine, Reirradiation)

Not yet recruiting
  • First Progression of Glioblastoma
  • (no location specified)
Jun 6, 2023

Prostate Carcinoma Trial in Jacksonville (Media Intervention, Survey Administration)

Recruiting
  • Prostate Carcinoma
  • Media Intervention
  • Survey Administration
  • Jacksonville, Florida
    Mayo Clinic in Florida
May 31, 2023

NSCLC Trial in Tianjing (Envalfolimab subcutaneously injected+Platinum-based doublet chemo intravenous injection,

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Envalfolimab subcutaneously injected+Platinum-based doublet chemotherapy intravenous injection
  • placebo subcutaneously injected +Platinum-based doublet chemotherapy intravenous injection
  • Tianjing, Tianjin, China
    Tianjin cancer hospital
Nov 3, 2023

NSCLC Trial in Shanghai (SY-5007)

Recruiting
  • Non-Small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Sep 4, 2023

Non Small Cell Lung Cancer Trial (TGRX-326, Crizotinib)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • (no location specified)
Oct 8, 2023

Bone Metastases Trial in Houston (Radiation Therapy)

Not yet recruiting
  • Bone Metastases
  • Radiation Therapy
  • Houston, Texas
    M D Anderson Cancer Center
Sep 26, 2023

Thyroid Cancer, Recurrence Trial in Beijing (prophylactic central neck dissection)

Recruiting
  • Thyroid Cancer
  • Recurrence
  • prophylactic central neck dissection
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Science
Oct 8, 2023

Otomycosis Trial (Miconazole (2%) oil and mineral oil, Placebo)

Not yet recruiting
  • Otomycosis
  • Miconazole (2%) oil and mineral oil
  • Placebo
  • (no location specified)
Dec 13, 2022

From Phase III to IV Cardiac Rehabilitation

Not yet recruiting
  • Cardiovascular Diseases
    • Caerleon, Gwent, United Kingdom
    • +2 more
    Mar 13, 2023

    HER2-PositiveRecurrent or Metastatic Breast Cancer Trial (SHR-A1811 Injection, SHR-A1811 Injection ; Pertuzumab Injection,

    Not yet recruiting
    • HER2-PositiveRecurrent or Metastatic Breast Cancer
    • SHR-A1811 Injection
    • +2 more
    • (no location specified)
    Sep 21, 2023

    Epidermolysis Bullosa Trial in Minneapolis (allo-APZ2-OTS, Placebo)

    Not yet recruiting
    • Epidermolysis Bullosa
    • Minneapolis, Minnesota
      Masonic Cancer Center and Medical Center Minneapolis
    Apr 20, 2023

    Respiratory Viral Infection Trial in Shanghai (ZX-7101A, Placebo)

    Not yet recruiting
    • Respiratory Viral Infection
    • Shanghai, Shanghai, China
      Fudan University affiliated Huashan Hospital
    Oct 19, 2023

    IgA Nephropathy Trial in Hangzhou (Telitacicept, Placebo)

    Not yet recruiting
    • IgA Nephropathy
    • Hangzhou, Zhejiang, China
      The Second Affiliated Hospital of Zhejiang University School of
    Oct 25, 2022

    GVHD Trial (Grafalon, Thymoglobulin)

    Not yet recruiting
    • GVHD
    • (no location specified)
    Oct 9, 2023

    HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy Trial (SHR-A1811,

    Not yet recruiting
    • HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy
    • (no location specified)
    Nov 7, 2023

    COVID-19 Trial in Manila (EuCorVac-19, ChAdOx1)

    Recruiting
    • COVID-19
    • EuCorVac-19
    • ChAdOx1
    • Manila, Philippines
      Trial site
    Oct 27, 2022

    Moderate to Severe Active Rheumatoid Arthritis Trial in Beijing (HS628+MTX, Actemra +MTX)

    Completed
    • Moderate to Severe Active Rheumatoid Arthritis
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Sep 14, 2023

    Atopic Dermatitis Trial in Beijing (Jaktinib Hydrochloride Tablet)

    Recruiting
    • Atopic Dermatitis
    • Jaktinib Hydrochloride Tablet
    • Beijing, Beijing, China
      11 Xizhimen South Street
    Jan 6, 2023

    COVID-19 SARS-CoV-2 Infection Trial (CoronaVac, SCTV01E)

    Not yet recruiting
    • COVID-19 SARS-CoV-2 Infection
    • CoronaVac
    • SCTV01E
    • (no location specified)
    Jan 4, 2023

    HER2-positive Breast Cancer Trial in Nanjing (HS022, Trastuzumab, Vinorelbine Bitartrate)

    Completed
    • HER2-positive Breast Cancer
    • Nanjing, Jiangsu, China
      Jiangsu Province People's Hospital (First Affiliated Hospital of
    Oct 25, 2023

    Anaplastic Oligoastrocytoma, Glioblastoma Trial in Guangzhou (Temozolomide)

    Recruiting
    • Anaplastic Oligoastrocytoma
    • Glioblastoma
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Oct 27, 2022